AzTrials
AzTrials

Quality of LifeNCT04237038

Quality of Life Results After Laparoscopic Fundoplication.

A study testing laparoscopic Nissen fundoplication short gastric vessel division in people with Quality of Life, run by Instituto Mexicano del Seguro Social.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The present study focuses on determining aspects of satisfaction and quality of life of patients that underwent laparoscopic Nissen fundoplication with or without short gastric vessel division (SGVD) and long-term differences. Read more about this study

Who is it for?
Ages 22 to 76 years
Conditions the study is for
Quality of Life
What is being tested?
laparoscopic Nissen fundoplication short gastric vessel division
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
87 participants
Where
No sites listed yet
Study dates
1 Feb 2013to 1 Dec 2014
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 22 to 76 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • 1) Patients who underwent surgery against Gastroesophageal Reflux with Nissen Fundoplication by Laparoscopic Pathway who were not divided into short gastric vessels during the procedure.
  • 2) Patients who underwent surgery against Gastroesophageal Reflux with Nissen Fundoplication by Laparoscopic Route who underwent a division of short gastric vessels during the procedure.
  • 3) Operated between October 2003 and November 2011 at the General Hospital of Zone # 1 "Dr. Leonel Ramírez García "of the IMSS Colima delegation.

Who cannot join

  • 1) Patients who underwent surgery against Gastroesophageal Reflux with Nissen Fundoplication by Laparoscopic Pathway who were not divided into short gastric vessels during the procedure.
  • 2) Patients who underwent surgery against Gastroesophageal Reflux with Nissen Fundoplication by Laparoscopic Route who underwent a division of short gastric vessels during the procedure.
  • 3) Operated between October 2003 and November 2011 at the General Hospital of Zone # 1 "Dr. Leonel Ramírez García "of the IMSS Colima delegation.

About this study

Official title: Long-term Quality of Life Results After Laparoscopic Fundoplication With and Without Short Gastric Vessel Division in Gastroesophageal Reflux Management

The present study focuses on determining aspects of satisfaction and quality of life of patients that underwent laparoscopic Nissen fundoplication with or without short gastric vessel division (SGVD) and long-term differences.

Read the detailed description

The aim of our study was to identify the degree of satisfaction and the quality of life of patients that underwent laparoscopic Nissen total fundoplication with or without SGVD.

Materials and methods. A randomized clinical trial was conducted with 87 patients submitted to laparoscopic Nissen fundoplication between February 2013 to december 2014 according to the guidelines established by the Mexican Consensus for the study of GERD.12 Inclusion criteria: 1) Patients who underwent surgery against Gastroesophageal Reflux with Nissen Fundoplication by Laparoscopic Pathway who were not divided into short gastric vessels during the procedure. 2) Patients who underwent surgery against Gastroesophageal Reflux with Nissen Fundoplication by Laparoscopic Route who underwent a division of short gastric vessels during the procedure. 3) Operated between October 2003 and November 2011 at the General Hospital of Zone # 1 "Dr. Leonel Ramírez García "of the IMSS Colima delegation. Exclusion criteria: 1)Patients in whom conversion to open surgery was performed. 2) Operated before October 2003 or after November 2011.3) Patients whose data is not available for their location. Disposal criteria:1) Patients not reachable for any reason.2. Patients who do not wish to participate. 3. Patients with incomplete medical information for research.

The patients were assigned into two groups: 43 patients that had SGVD and 44 patients in whom the short gastric vessels were left intact. Seven patients were lost during the follow-up, leaving 40 patients in the SGVD group and 40 in the group without SGVD. The mean follow-up time was 5±0,5 years (4 to 6 years) and the Nissen total fundoplication was the only surgical procedure performed by the authors. Complications, hospital stay, and surgical time (secondary aims) were identified in a blinded fashion. The time it took to return to daily activities, the degree of satisfaction measured, quality of life, and symptom persistence (primary aims) were identified through standardized questionnaires that were previously validated for that purpose. The level of satisfaction, quality of life of the postopera-tive patients, and surgical morbidity were evaluated through standardized and validated questionnaires elaborated for that purpose. The Carlsson questionnaire was applied to all the patients in order to measure reflux intensity; quality of life was studied postoperatively through the GIQLI (an adequate,valid,and useful instrument for evaluating quality of life in patients presenting with reflux disease)because it includes specific questions about digestive symp-toms and generic questions about physical,emotional,and social capacity.The questionnaire contains 36 items with an answer scale from0(the worst result) to 4(the best result).Global scores above 86 were regarded as a satisfactory effect, even in the presence of residual symptoms.Dysphagia was evaluated with the Dysphagia score,the Analog scale for dysphagia,and the Visick grading system.The questionnaire dealing with the level of satisfaction and quality of life was applied to each patient that had a minimum5-year postoperative period; it was applied verbally and the questions were asked by a researcher uninvolved in the surgical management.The level of satisfaction was evaluated nominally with the following questions:Would you accept being operated on again? Would you recommend the procedure to a friend or familymember? TheGIQLI was chosen because it is a validated questionnaire n Spanish.It consists of 36 questions divided in to 5 sections,with a specific part for digestive diseases.Scoring and the visual analog for dysphagia were measured through validated sco-ring scales,whereas the Visick scale was measured ordinally.

Statistical analysis. A database was designed (Microsoft Excel) and the statistical analysis was done through the IBM SPSS Statistics ver. 21 (©copyright IBM Corporation) program. The comparative analysis of the groups was carried out under the principles of intention-to-treat. Descriptive statistics were used as mean, standard deviation and percentages. The comparison of averages between groups was performed using Student t or Mann-Whitney U tests (for equal variances or different respectively). The percentage comparison was made with Chi-square or Fisher exact tests. While the pairwise comparison of ordinal variables Wilcoxon test was used. In all statistical test, a confidence interval of 95% was used. Statistical significance was set at a p<0,05.

Conditions
Quality of Life
Being tested
laparoscopic Nissen fundoplication short gastric vessel division
Keywords
Laparoscopic fundoplication, Short gastric vessel

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • laparoscopic Nissen fundoplication short gastric vessel divisionProcedure or surgery

    Randomized clinical trial conducted in forty patients submitted to SGVD and forty patients without SGVD. Patients were evaluated with standarized questionnaires to measure the degree of satisfaction in relation to surgical procedure and to the quality of life. A randomized clinical trial was conducted with 87 patients submitted to laparoscopic Nissen fundoplication between February 2013 to december 2014 according to the guidelines established by the Mexican Consensus for the study of Gastroesophageal reflux disease (GERD

Study groups in NCT04237038
Study groupRoleWhat they receive
laparoscopic Nissen fundoplication short gastric vessel diviExperimentalRandomized clinical trial conducted in forty patients submitted to short gastric vessel division (SGVD) forty patients without SGVD. Patients were evaluated with standarized questionnaires to measure the degree of satisfaction in relation to surgical procedure and to the quality of life.
Receives: Procedure: laparoscopic Nissen fundoplication short gastric vessel division

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Carlsson questionnaire

    Carlsson questionnaire was applied to all the patients in order to measure reflux intensity. A total score between -7 and +18 points is obtained. Consider a score greater than or equal to 4 as positive for GERD.

    Measured: five years

  2. Gastrointestinal Quality of Life Index (GIQLI) Gastrointestinal Quality of Life Index: GIQLI Gastrointestinal Quality of Life Index: GIQLI

    evaluating quality of life in patients presenting with reflux disease.The maximum GIQLI in the international score is 144 and its worst value is 0

    Measured: five years

  3. Visick grading system

    Scale used to assess the assessment of patients regarding antireflux surgery, both openly and laparoscopically. The patient globally assesses the subjective outcome of the surgery: 1 = cured / asymptomatic, 2 = improved / scarce symptoms without the need for medical treatment, 3 = no significant changes / symptoms that require medical treatment, and 4 = worsened / great symptomatology.

    Measured: five years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Jan 2020
  2. Study start1 Feb 2013
  3. Primary completion1 Nov 2014
  4. Study completion1 Dec 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Intervention model
Sequential
Model description
A randomized clinical trial was conducted with patients submitted to laparoscopic Nissen fundoplication between February 2013 to december 2014 according to the guidelines established by the Mexican Consensus for the study of GERD.
Masking
None (open label)
Enrolment
87 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04237038
Sponsor's protocol ID
R-2013-601-8
Status last verified
Jan 2020
First submitted
28 Nov 2019
Last updated
22 Jan 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Prieto-Diaz-Chavez E, Medina-Chavez JL, Brizuela-Araujo CA, Gonzalez-Jimenez MA, Mellin-Landa TE, Gomez-Garcia TS, Gutierrez-Zamora J, Trujillo-Hernandez B, Millan-Guerrero R, Vasquez C. Patient satisfaction and quality of life following laparoscopic Nissen fundoplication. Rev Gastroenterol Mex. 2014 Apr-Jun;79(2):73-8. doi: 10.1016/j.rgmx.2013.11.003. Epub 2014 May 27. English, Spanish.

    PubMed 24878219

Questions about this trial

What is this clinical trial studying?

A study testing laparoscopic Nissen fundoplication short gastric vessel division in people with Quality of Life, run by Instituto Mexicano del Seguro Social.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Jan 2020. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Carlsson questionnaire (time frame: five years). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04237038, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jan 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in